» Articles » PMID: 2524599

Viral Protein R of Human Immunodeficiency Virus Types 1 and 2 is Dispensable for Replication and Cytopathogenicity in Lymphoid Cells

Overview
Journal J Virol
Date 1989 Jul 1
PMID 2524599
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Viral protein R (VPR) is conserved in human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2). To assess its function, we have constructed mutations within the vpr coding regions of HIV-1 and HIV-2 predicted to express truncated VPR products. Infectious virus was produced by each proviral clone and showed similar replication kinetics and cytopathogenicity when compared with the corresponding parental proviral clone.

Citing Articles

HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages.

Virgilio M, Ramnani B, Chen T, Disbennett W, Lubow J, Welch J Nat Commun. 2024; 15(1):5514.

PMID: 38951492 PMC: 11217462. DOI: 10.1038/s41467-024-49635-w.


The Interplay Among HIV, LINE-1, and the Interferon Signaling System.

Zhao X, Zhao Y, Du J, Gao P, Zhao K Front Immunol. 2021; 12:732775.

PMID: 34566998 PMC: 8459832. DOI: 10.3389/fimmu.2021.732775.


HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport.

Khan H, Sumner R, Rasaiyaah J, Tan C, Rodriguez-Plata M, van Tulleken C Elife. 2020; 9.

PMID: 33300875 PMC: 7759385. DOI: 10.7554/eLife.60821.


Protein Arginine -methyltransferases 5 and 7 Promote HIV-1 Production.

Murakami H, Suzuki T, Tsuchiya K, Gatanaga H, Taura M, Kudo E Viruses. 2020; 12(3).

PMID: 32210193 PMC: 7150949. DOI: 10.3390/v12030355.


Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression.

Wang Q, Su L mBio. 2019; 10(4).

PMID: 31431548 PMC: 6703422. DOI: 10.1128/mBio.01344-19.


References
1.
Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R . Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-9. PMC: 350514. DOI: 10.1073/pnas.77.12.7415. View

2.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

3.
Kunkel T . Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985; 82(2):488-92. PMC: 397064. DOI: 10.1073/pnas.82.2.488. View

4.
Sonigo P, Alizon M, Staskus K, Klatzmann D, Cole S, Danos O . Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell. 1985; 42(1):369-82. DOI: 10.1016/s0092-8674(85)80132-x. View

5.
Oshimura M, Gilmer T, Barrett J . Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes. Nature. 1985; 316(6029):636-9. DOI: 10.1038/316636a0. View